thiophenes has been researched along with Lymphoma, Large B-Cell, Diffuse in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 3 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ammatuna, E; de Jong, MRW; Langendonk, M; Nijland, M; Reitsma, B; van den Berg, A; van Meerten, T; Visser, L | 1 |
| Bala Tannan, N; Da Silva Ferreira, M; de Stanchina, E; Hagen, C; Heller, DA; Herviou, L; Kiguchi, H; Manova-Todorova, K; Manzari, MT; Seshan, V; Younes, A | 1 |
| Gao, J; Li, T; Lwin, T; Ren, Y; Shah, BD; Shain, KH; Tao, J; Wang, MY; Zhang, W; Zhao, X | 1 |
| Agostinelli, C; Alcalay, M; Baiardi, E; Bertolini, F; Calleri, A; Casadei, B; Corsini, C; Derenzini, E; Falvo, P; Fiori, S; Mazzara, S; Melle, F; Motta, G; Orecchioni, S; Pelicci, PG; Pileri, S; Rossi, A; Tabanelli, V; Tarella, C; Vitolo, U; Zinzani, PL | 1 |
| Bacon, CM; Bell, N; Blair, H; Bomken, S; Critchlow, SE; Crossland, R; Keun, HC; Long, A; Miwa, S; Nakjang, S; Noble, RA; Phillips, N; Rand, V; Sikka, A; Televantou, D; Thomas, H; Wedge, SR | 1 |
| Gao, X; Jiao, J; Sang, W; Sun, XK; Xu, KL; Xu, LY; Yang, P | 1 |
| Afonso, J; Baltazar, F; Longatto-Filho, A; Marques, H; Pinheiro, C; Pinto, T; Schmitt, F; Simões-Sousa, S | 1 |
| Agostinelli, C; Brighenti, E; Casadei, B; Derenzini, E; Ferrari, A; Fuligni, F; Ghelli Luserna Di Rorà, A; Iacobucci, I; Imbrogno, E; Martinelli, G; Pileri, S; Righi, S; Zinzani, PL | 1 |
| Da-Rè, C; Halazonetis, TD | 1 |
| Arribas, AJ; Bertoni, F; Carrassa, L; Damia, G; Restelli, V; Vagni, M | 1 |
| Alberto, P; Giger, K; Nagel, G; Senn, HJ; Sonntag, RW | 1 |
2 trial(s) available for thiophenes and Lymphoma, Large B-Cell, Diffuse
| Article | Year |
|---|---|
Dual targeting of the DNA damage response pathway and BCL-2 in diffuse large B-cell lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers, Tumor; Bridged Bicyclo Compounds, Heterocyclic; DNA Repair Enzymes; Drug Therapy, Combination; Female; Follow-Up Studies; Gene Expression Regulation, Leukemic; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prognosis; Prospective Studies; Proto-Oncogene Proteins c-bcl-2; Retrospective Studies; Sulfonamides; Survival Rate; Thiophenes; Urea; Young Adult | 2022 |
Clinical screening of epipodophyllotoxin VM26 in malignant lymphomas and solid tumours.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Alopecia; Anemia, Aplastic; Antineoplastic Agents; Blood Platelet Disorders; Child; Clinical Trials as Topic; Female; Gastrointestinal Diseases; Glycosides; Hematopoiesis; Hodgkin Disease; Humans; Lactones; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Plants, Medicinal; Plants, Toxic; Podophyllum; Remission, Spontaneous; Thiophenes; Urinary Bladder Neoplasms | 1972 |
10 other study(ies) available for thiophenes and Lymphoma, Large B-Cell, Diffuse
| Article | Year |
|---|---|
Heterogeneous Pattern of Dependence on Anti-Apoptotic BCL-2 Family Proteins upon CHOP Treatment in Diffuse Large B-Cell Lymphoma.
Topics: Aniline Compounds; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bcl-2-Like Protein 11; bcl-X Protein; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Cell Survival; Cyclophosphamide; Doxorubicin; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Lymphoma, Large B-Cell, Diffuse; Myeloid Cell Leukemia Sequence 1 Protein; Prednisone; Prognosis; Proto-Oncogene Proteins c-bcl-2; Pyrimidines; Rituximab; Signal Transduction; Sulfonamides; Thiophenes; Treatment Outcome; Vincristine | 2019 |
Tumor-targeted nanoparticles improve the therapeutic index of BCL2 and MCL1 dual inhibition.
Topics: Animals; Antineoplastic Agents; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Drug Carriers; Drug Delivery Systems; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Mice; Myeloid Cell Leukemia Sequence 1 Protein; Nanoparticles; Proto-Oncogene Proteins c-bcl-2; Pyrimidines; Sulfonamides; Therapeutic Index; Thiophenes | 2021 |
MCL-1 dependency as a novel vulnerability for aggressive B cell lymphomas.
Topics: Antineoplastic Agents; Cell Line, Tumor; Drug Resistance, Neoplasm; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Myeloid Cell Leukemia Sequence 1 Protein; Pyrimidines; Signal Transduction; Thiophenes; Transcriptome | 2021 |
Inhibition of monocarboxyate transporter 1 by AZD3965 as a novel therapeutic approach for diffuse large B-cell lymphoma and Burkitt lymphoma.
Topics: Antineoplastic Agents; Biomarkers; Burkitt Lymphoma; Cell Death; Cell Line, Tumor; Drug Resistance, Neoplasm; Electron Transport Complex I; Energy Metabolism; Humans; Lactic Acid; Lymphoma, Large B-Cell, Diffuse; Mitochondria; Monocarboxylic Acid Transporters; Muscle Proteins; Oxidative Phosphorylation; Pyrimidinones; Symporters; Thiophenes | 2017 |
[Effect of IKK2 Inhibitor LY2409881 on Diffuse Large B-Cell Lymphoma Cell Apoptosis and Its Mechanism].
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Humans; I-kappa B Kinase; Lymphoma, Large B-Cell, Diffuse; Pyrimidines; Thiophenes | 2018 |
Clinical significance of metabolism-related biomarkers in non-Hodgkin lymphoma - MCT1 as potential target in diffuse large B cell lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Cell Line, Tumor; Cell Survival; Female; Glycolysis; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Monocarboxylic Acid Transporters; Pyrimidinones; Symporters; Thiophenes; Young Adult | 2019 |
Constitutive activation of the DNA damage response pathway as a novel therapeutic target in diffuse large B-cell lymphoma.
Topics: Antineoplastic Agents; Apoptosis; Benzodiazepinones; cdc25 Phosphatases; Cell Line, Tumor; Cell Proliferation; Checkpoint Kinase 1; Checkpoint Kinase 2; DNA Damage; Dose-Response Relationship, Drug; Histones; Humans; Lymphoma, Large B-Cell, Diffuse; Molecular Targeted Therapy; Phosphorylation; Protein Kinase Inhibitors; Protein Kinases; Proto-Oncogene Proteins c-myc; Pyrazoles; Thiophenes; Time Factors; Tumor Cells, Cultured; Urea | 2015 |
DNA replication stress as an Achilles' heel of cancer.
Topics: Antineoplastic Agents; Benzodiazepinones; Checkpoint Kinase 2; DNA Damage; Humans; Lymphoma, Large B-Cell, Diffuse; Protein Kinase Inhibitors; Protein Kinases; Pyrazoles; Thiophenes; Urea | 2015 |
Inhibition of CHK1 and WEE1 as a new therapeutic approach in diffuse large B cell lymphomas with MYC deregulation.
Topics: Cell Cycle Proteins; Cell Line; Checkpoint Kinase 1; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Nuclear Proteins; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-myc; Pyrazoles; Pyrimidines; Pyrimidinones; Thiophenes; Urea | 2018 |
Experience with 4'-demethylepipodo-phyllotoxin 9-(4,6-o-2-thenylidene-beta-D-glucopyranoside); VM-26; NSC-122819 in the treatment of malignant lymphosis.
Topics: Adult; Aged; Antineoplastic Agents; Blood Platelet Disorders; Dose-Response Relationship, Drug; Female; Glucosides; Glycosides; Hodgkin Disease; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Podophyllotoxin; Remission, Spontaneous; Thiophenes | 1974 |